Table 1 Patient characteristics

From: Brain natriuretic peptide precursor (NT-pro-BNP) levels predict for clinical benefit to sunitinib treatment in patients with metastatic renal cell carcinoma

Patient characteristics		%
Number
Total included	36	100
Assessable for response	36	100
Sex
Male	26	72
Female	10	28
Age
Median	62
Range	25-75
Performance status
0	16	44.4
1	16	44.4
2	4	11.1
MSKCC criteria
Low risk	2	5.6
Intermediate risk	15	41.7
High risk	19	48.7
Previous treatments
Nephrectomy	30	83.3
Cytokines	15	41.7
Radiotherapy	10	27.8
Metastatic sites
Lung	24	66.7
Bone	10	27.8
Lymph nodes	7	19.4
Liver	4	11.1
Local relapse	2	5.6
Other	5	13.9

Back to article page